Please visit the Infectious Diseases homepage here.
The National Institute for Health and Care Excellence (NICE) does not recommend Zykadia (ceritinib) from Novartis, for use in ALK+...
Amgen announced the submission of a Biologics License Application (BLA) with the FDA for ABP 501, a biosimilar candidate to Humira...
Indivior Inc., a subsidiary of Indivior PLC announced that it has received a Complete Response Letter from the FDA regarding its New Drug...
A FREE CME activity: ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’ is now available to complete on EPGonline.org
Go to CME >